ARCHIVES

NCI Issues Statement On Endostatin Research

This article is from The Cancer Letter archive.

Vol. 25 No. 37 | October 1, 1999

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Offers Grant Supplements

March 5, 1999

Cancer Patients Satisfied With Experience In Clinical Trials, Survey Of 2,000 Finds

July 28, 2006

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

Daily Humidification Improves Quality-of-Life in Phase III Trial

February 28, 2014

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

April 25, 1980

Cancer Policy: NCAB Chairmen sent Letter To Senator Defending NCI director

April 11, 1997